Association of Hypertension, Diabetes, and Cardiovascular Disease with COVID-19 in Africa: Scoping Review Protocol

Faisal Nooh1,2,3,4, Jürg Utzinger1,2, Daniel H Paris1,2

  • 1Swiss Tropical and Public Health Institute, Kreuzstrasse 2, CH-4123 Allschwil, Switzerland.

Insights

This scoping review examines COVID-19 severity in African patients with noncommunicable diseases (NCDs). Findings will inform management strategies for hypertension, diabetes, and cardiovascular diseases during pandemics.

Area of Science:

  • Public Health
  • Epidemiology
  • Infectious Diseases

Background:

  • COVID-19 significantly impacted global healthcare, with higher mortality in the elderly and those with chronic conditions.
  • Limited data exists on the association between COVID-19 severity and noncommunicable diseases (NCDs) in African populations.

Purpose of the Study:

  • To estimate COVID-19 severity in African patients diagnosed with hypertension, diabetes, and cardiovascular diseases (CVDs).
  • To explore the implications of these associations for effective case management strategies.

Main Methods:

  • A scoping review adhering to PRISMA-ScR guidelines.
  • Comprehensive literature search across major databases (PubMed, Scopus, Web of Science, Embase, CINAHL, JBI).
  • Data extraction by two reviewers for articles published post-March 2020, followed by descriptive and narrative synthesis.

Main Results:

  • The review is expected to quantify the increased risk of severe COVID-19 among patients with pre-existing NCDs.
  • Identification of key trends and data gaps regarding NCDs and COVID-19 severity in Africa.

Conclusions:

  • This review will establish an evidence base to guide recommendations for surveillance systems and referral guidelines.
  • Findings will support improved management of NCDs during COVID-19 and future pandemics in African healthcare settings.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
28
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
33
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
22
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
24
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
605